Taher A - Search Results

1

Circulating microparticles and the risk of thromboembolic events in Egyptian beta thalassemia patients.

Youssry I, Soliman N, Ghamrawy M, Samy RM, Nasr A, Abdel Mohsen M, ElShahaat M, Bou Fakhredin R, Taher A. Youssry I, et al. Among authors: taher a. Ann Hematol. 2017 Apr;96(4):597-603. doi: 10.1007/s00277-017-2925-x. Epub 2017 Feb 7. Ann Hematol. 2017. PMID: 28168351

2

Pulmonary thromboembolism in beta-thalassemia intermedia: are we aware of this complication?

Taher A, Abou-Mourad Y, Abchee A, Zalouaa P, Shamseddine A. Taher A, et al. Hemoglobin. 2002 May;26(2):107-12. doi: 10.1081/hem-120005447. Hemoglobin. 2002. PMID: 12144052 Review.

3

Beta-thalassemia intermedia and non-Hodgkin's lymphoma.

Chehal A, Loutfi R, Taher A. Chehal A, et al. Among authors: taher a. Hemoglobin. 2002 Aug;26(3):219-25. doi: 10.1081/hem-120015025. Hemoglobin. 2002. PMID: 12403486 Review.

4

Non-Hodgkin disease in beta-thalassemia major.

Otrock ZK, Shamseddine AI, Taher AT. Otrock ZK, et al. Am J Hematol. 2006 Jan;81(1):62-4. doi: 10.1002/ajh.20463. Am J Hematol. 2006. PMID: 16369971 Free article.

5

Pregnancy in patients with beta-thalassemia intermedia: outcome of mothers and newborns.

Nassar AH, Usta IM, Rechdan JB, Koussa S, Inati A, Taher AT. Nassar AH, et al. Among authors: taher at. Am J Hematol. 2006 Jul;81(7):499-502. doi: 10.1002/ajh.20654. Am J Hematol. 2006. PMID: 16755576 Free article.

6

Intravenous zoledronic acid treatment in thalassemia-induced osteoporosis: results of a phase II clinical trial.

Otrock ZK, Azar ST, Shamseddeen WA, Habr D, Inati A, Koussa S, Mahfouz RA, Taher AT. Otrock ZK, et al. Among authors: taher at. Ann Hematol. 2006 Sep;85(9):605-9. doi: 10.1007/s00277-006-0136-y. Epub 2006 Jul 8. Ann Hematol. 2006. PMID: 16830143 Clinical Trial.

7

Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran.

Taher A, Isma'eel H, Mehio G, Bignamini D, Kattamis A, Rachmilewitz EA, Cappellini MD. Taher A, et al. Thromb Haemost. 2006 Oct;96(4):488-91. Thromb Haemost. 2006. PMID: 17003927

8

Screening for inherited thrombophilia might be warranted among Eastern Mediterranean sickle-beta-0 thalassemia patients.

Isma'eel H, Arnaout MS, Shamseddeen W, Mahfouz R, Zeineh N, Jradi O, Taher A. Isma'eel H, et al. Among authors: taher a. J Thromb Thrombolysis. 2006 Oct;22(2):121-3. doi: 10.1007/s11239-006-8953-3. J Thromb Thrombolysis. 2006. PMID: 17008978

9

Ocular findings among thalassemia patients.

Taher A, Bashshur Z, Shamseddeen WA, Abdulnour RE, Aoun E, Koussa S, Baz P. Taher A, et al. Am J Ophthalmol. 2006 Oct;142(4):704-5. doi: 10.1016/j.ajo.2006.04.030. Am J Ophthalmol. 2006. PMID: 17011879

10

Effect of L-carnitine on the physical fitness of thalassemic patients.

El-Beshlawy A, El Accaoui R, Abd El-Sattar M, Gamal El-Deen MH, Youssry I, Shaheen N, Hamdy M, El-Ghamrawy M, Taher A. El-Beshlawy A, et al. Among authors: taher a. Ann Hematol. 2007 Jan;86(1):31-4. doi: 10.1007/s00277-006-0181-6. Epub 2006 Oct 10. Ann Hematol. 2007. PMID: 17031691 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

954 results

Search Page